Expanded Program for Immunization, a Missed Opportunity for Postpartum Family Planning Utilization

March 1, 2021 updated by: Abebaw Abeje Muluneh, Hawassa University

Enhancing Postpartum Family Planning Utilization Through Integration With Expanded Program for Immunization in Sidama, South Ethiopia: A Quasi Experimental Study

This study is aimed to enhance postpartum family planning by integrating family planning information with infant immunization services, which is the most widely utilized health services globally.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

In this study, a before-and-after type of quasi-experimental study will be conducted in purposely selected health centers Sidama region, Ethiopia. base line assessment of postpartum contraceptive utilization rate will be done which will be followed by an intervention. The intervention consists of screening, counseling for family planning and referring mothers coming for infant immunization services to family planning units. All mothers coming for infant immunization service will be screened for and counseled for family planning and those who will be voluntary to take any method will be referred to family planning unit. All mothers who will not be voluntary will be re-counseled by the next visit.

Finally, the effect of this intervention on postpartum contraceptive utilization rate will be reassessed. The expected outcome will be to see an improved contraceptive uptake during the first year after delivery.

Study Type

Interventional

Enrollment (Anticipated)

1474

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Ethiopia
    • Sidama
      • Hawassa, Sidama, Ethiopia
        • Sidama regional health bureau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • all women visiting health facilities for infant immunization for at least two times will be included.

Exclusion Criteria:

  • Women who are in difficulty of communicating during the study period will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Pre-intervention group
Pre-intervention group: women participated during the base line assessment will be labeled as Pre-intervention group
Experimental: postintervention group
Postintervention group: women participated after the intervention was initiated will be labeled as postintervention group.
Other: counseling
Mothers presented to infant immunization units are going to be counseled for family planning services and if decide to take any method, they will be linked to family planning services

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
After the initiation of the intervention, improved Contraceptive prevalence rate will be expected as an outcome
Time Frame: the outcome is measured two months after the initiation of the intervention
After counseling of the postpartum mothers for family planning, their informed decision making capacity to use contraceptives will be increased.
the outcome is measured two months after the initiation of the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hawassa University

Investigators

  • Principal Investigator: Abebaw Muluneh, Hawassa University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

August 30, 2020

Study Completion (Anticipated)

March 17, 2021

Study Registration Dates

First Submitted

January 30, 2021

First Submitted That Met QC Criteria

March 1, 2021

First Posted (Actual)

March 3, 2021

Study Record Updates

Last Update Posted (Actual)

March 3, 2021

Last Update Submitted That Met QC Criteria

March 1, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • abe16muluneh

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Contraceptive Usage

Clinical Trials on counseling

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe